Mito Health
Mid-priced longevity membership with included 1:1 clinician consult and serious aging-science advisory bench
NOT CLEARED
No FDA clearance, registration, or CE marking found.
Key facts at a glance.
- Founded
- 2023
- Headquarters
- San Francisco, CA, USA
- Price range
- $680–$949
- App ratings
- iOS 4.7
The real price over three years.
Total cost of ownership · 3yr
| Hardwareone-time | $680 |
| 3-year total | $680 |
What the device does.
- + 100+ biomarker core panel
- + Biological-age calculation from blood data
- + 1:1 licensed clinician consultation included
- + AI-powered action plan
- + Advisors from Buck Institute and Healthy Aging & Longevity Institute
- + Galleri multi-cancer add-on
- + Nationwide lab network (all 50 states)
The trade-offs.
- + **100+ biomarker core panel** — competitive with Function Health, substantially exceeds Superpower's verified ~55
- + **Licensed clinician consultation included** — Lifeforce-tier integration at lower membership cost
- + Buck Institute and Healthy Aging & Longevity Institute scientific advisors — credible aging-science backing
- + Galleri multi-cancer add-on integration — only DTC platform offering this at scale
- + Nationwide lab network across all 50 US states
- − 2023-founded with limited longitudinal track record vs Function Health (2020) or InsideTracker (2009)
- − Smaller US footprint and brand recognition than category leaders
- − Venous draw required (Quest network) — not home collection like Function Health's pathway
- − $680–$949 pricing is mid-tier expensive; membership economics depend on retest frequency
- − Limited consumer review volume vs more-established competitors
Longevity consumers wanting biological-age insights and AI-powered preventive care
The long read.
§ Hands-on instrument testing pending. Based on published specifications and third-party data.
Overview
Mito Health is the direct Function Health challenger in the consumer DTC blood-test category — founded 2023 in San Francisco, with a product structure designed to compete head-to-head with Function Health’s 110+ biomarker model while adding clinician-consultation integration that Function Health doesn’t offer.
The structural value claim: 100+ biomarker core panel at $680/year, with licensed clinician consultation included (not separately upsold). For comparison: Function Health offers similar biomarker count without clinician integration; Lifeforce offers clinician integration at $349/mo ($4,188/yr). Mito Health splits the difference — comprehensive biomarker breadth + clinician access at sub-$1,000 annual cost.
The structural editorial caveat: 2023-founded — limited longitudinal track record vs Function Health, InsideTracker, or LetsGetChecked. Brand recognition is weaker; consumer review volume is limited; operational maturity is still developing. For buyers willing to bet on rapid-execution startups against established incumbents, Mito Health is structurally interesting. For buyers prioritizing track record and brand recognition, Function Health is the safer choice.
What We Measured
Note: This review is based on Mito Health’s published panel specifications, scientific advisor positioning, Galleri integration documentation, and aggregated user reports. Hands-on testing of the membership experience (collection logistics, clinician depth, app usability) is pending.
The 100+ biomarker panel
Mito Health’s core panel covers 100+ biomarkers across hormones, metabolic, lipids, vitamins, inflammation, kidney/liver function, oxygen carriers, electrolytes, and longevity-relevant markers (homocysteine, ApoB, advanced lipid subfractions where included).
This is competitive with Function Health’s 110+ biomarker panel. The substantive difference: Function Health markets aggressively on biomarker count; Mito Health markets on biomarker count + clinician + biological-age + Galleri integration.
For buyers prioritizing maximum biomarker count, Function Health and Mito Health are structurally similar. The differentiation comes from the integration layers above the data.
The clinician consultation integration
This is the structural Function Health gap that Mito Health fills. Membership includes 1:1 licensed clinician consultation for results review and protocol guidance.
Compare:
- Function Health: data + portal, no clinician
- Mito Health: data + clinician (included in membership)
- Lifeforce: data + clinician + prescriptions ($349/mo)
- Superpower: data + AI chat + supplement marketplace, no licensed clinician
For buyers who want biomarker data + licensed clinician interpretation without paying Lifeforce’s $349/mo concierge premium, Mito Health is structurally the leading choice in the consumer market.
The clinician depth is meaningfully different from Lifeforce’s prescription-pathway capability — Mito Health provides interpretation and protocol guidance but does not have Lifeforce’s HRT/GLP-1/peptide prescription integration. Different category positioning at different price points.
The Buck Institute / Healthy Aging & Longevity Institute advisory
Mito Health’s scientific advisors include researchers from the Buck Institute for Research on Aging (one of the most-respected aging-science research institutions globally) and the Healthy Aging & Longevity Institute.
This is credible aging-science backing. For buyers who weight academic-research portfolio depth, Mito Health’s advisor selection is competitive with InsideTracker’s Harvard/Tufts/MIT board and stronger than Function Health’s medical-advisor positioning.
The honest framing: scientific advisor lists are marketing signals, not direct product validation. Buck Institute association is meaningful but doesn’t guarantee Mito Health’s algorithms reflect the depth of the advisors’ research portfolios. Buyers should weight advisor presence as one signal among several.
The Galleri multi-cancer add-on
Mito Health is the only major DTC blood-test platform offering integrated Galleri multi-cancer screening as an add-on. Galleri detects multiple cancer types via methylation-based bloodwork analysis — different methodology from standard biomarker panels.
The add-on cost is substantial ($949 for the panel including Galleri), but the integrated workflow (single membership, single collection event) is structurally meaningful for users who want comprehensive cancer screening without separate vendor relationships.
For users at elevated cancer risk (family history, age >50, etc.), the Galleri integration is a category-unique advantage. For users without elevated risk, the add-on cost may not be justified.
The biological-age calculation
Mito Health includes biological-age calculation based on the bloodwork. Methodology details are less transparently published than InsideTracker’s InnerAge 2.0 (which has the most-validated consumer biological-age methodology). Treat Mito Health’s biological-age score as a wellness-tier metric for trend tracking within the platform.
3-Year Cost of Ownership
| Use case | Annual cost | 3-year total |
|---|---|---|
| Mito Health Core (100+ biomarkers + clinician) | ~$680 | ~$2,040 |
| Mito Health + Galleri | ~$949 | ~$2,847 |
| Quarterly retest cadence (Core × 4) | ~$2,720 | ~$8,160 |
Compare: Function Health ($1,497 / 3 yr, no clinician), Lifeforce ($12,564 / 3 yr at $349/mo), InsideTracker ($1,020 / 3 yr Ultimate panel), Superpower ($597 / 3 yr).
Mito Health’s pricing is mid-tier expensive but structurally well-positioned: cheaper than Lifeforce’s clinician-included concierge, more inclusive than Function Health’s data-only model.
Regulatory Status
Not FDA-Cleared. Standard for the DTC blood-test category. Lab partner credentials (Quest Diagnostics network) cover the regulatory pathway. Galleri integration operates under its own regulatory positioning (lab-developed test under CLIA framework).
When Mito Health Makes Sense — And When It Doesn’t
Strong fit:
- You want biomarker breadth + clinician integration at sub-$1,000 annual cost
- You’re at elevated cancer risk and want integrated Galleri multi-cancer screening
- You value Buck Institute advisor backing as a credibility signal
- You’re comfortable with a 2023-founded brand at rapid-execution maturity
- You want a direct Function Health challenger with clinician integration Function lacks
Weaker fit:
- You want established track record — Function Health, InsideTracker, LetsGetChecked have longer operating history
- You want prescription pathway integration (HRT, GLP-1) — Lifeforce is structurally better
- You want home collection — Mito Health requires Quest venous draw, not finger-prick at home
- You want data-only without clinician overhead — Function Health is structurally simpler
- You’re cost-sensitive — Superpower or InsideTracker mini-panels are cheaper
Verdict: Recommended
Mito Health earns a recommended verdict on the strength of its 100+ biomarker panel (competitive with Function Health), included licensed clinician consultation (filling the Function Health gap), Buck Institute / Healthy Aging & Longevity Institute scientific advisor backing, and category-unique integrated Galleri multi-cancer screening.
For buyers seeking comprehensive biomarker breadth + clinician integration without paying Lifeforce concierge premium, Mito Health is structurally the leading mid-tier choice. The combination of biomarker depth + clinician access + Galleri integration is unique in the consumer market at sub-$1,000 annual cost.
For buyers prioritizing established track record, prescription-pathway integration, or data-only minimalism, Function Health, Lifeforce, or InsideTracker remain structurally better matches. Mito Health is the comprehensive-membership challenger — buyers willing to bet on a 2023-founded rapid-execution startup will find it materially differentiated from incumbents.
Changelog
- 2026-05-06: Initial review published based on Mito Health’s published panel specifications, scientific advisor positioning, Galleri integration documentation, and aggregated user-report data.